Clinical Trials Logo

Clinical Trial Summary

This study is aiming to demonstrate the non-inferiority of AbobotulinumtoxinA (aboBoNT-A) versus OnabotulinumtoxinA (onaBoNT-A) as the primary safety endpoint, and the superiority of aboBoNT-A over onaBoNT-A with respect to duration of response as the key secondary efficacy endpoint when used at optimal doses according to approved prescribing information of each product.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04936542
Study type Interventional
Source Ipsen
Contact Ipsen Recruitment Enquiries
Phone see email
Email clinical.trials@ipsen.com
Status Recruiting
Phase Phase 4
Start date June 23, 2021
Completion date June 28, 2025

See also
  Status Clinical Trial Phase
Completed NCT02454803 - Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice
Completed NCT00945295 - Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity N/A
Active, not recruiting NCT05956509 - Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity Phase 1/Phase 2
Completed NCT00465738 - IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity Phase 3
Completed NCT02321436 - Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression Phase 4
Completed NCT00430196 - BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity Phase 4
Completed NCT03821402 - Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity Phase 2
Terminated NCT02888548 - Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing Dynamic Hand Splinting in Adults With Post-stroke Hemiplegia (Orthox) N/A
Completed NCT01863901 - Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device N/A